Almost Public: Interagency Meeting Replaces US FDA ‘25-’26 Flu Vaccine AdComm

Only government staff participated in the meeting defining the next season’s influenza vaccine composition after the annual public FDA vaccines advisory committee meeting was cancelled.

The selection of influenza strains for the 2025-2026 vaccine took place out of public view. (Shutterstock)

More from Vaccines

More from Pathways & Standards